Four years after Kevin T. Conroy took the top job at a struggling biotech company, Exact Sciences Corp. said Monday it has submitted an application to federal regulators for approval to market a DNA-based, non-invasive colon cancer test. Read the full Milwaukee Journal Sentinel story here.
- Emerging firms will pitch over two days at 2021 Early Stage Symposium in MadisonOctober 26, 2021
- Badger Herald: Wisconsin Alumni Research Foundation announces record-breaking donation to UWOctober 26, 2021
- The ‘office’ is open! Industry experts on hand for advice at 2021 Early Stage SymposiumOctober 25, 2021
- WisconsinINNO: Gateway Capital Partners makes first investment as lead funder in Tip a ScRxipt seed roundOctober 25, 2021
- Madison Startups: Redox Launches New Connector for Microsoft CloudOctober 25, 2021